Sterile barriers "not packaging" says industry:
This article was originally published in Clinica
Sterile barrier systems should not be considered as packaging and not be regulated under the Packaging and Packaging Waste Directive. This is the message that Eucomed is aiming to convey to the European Commission. It is currently collecting details to support its argument and has posted a questionnaire on its website to help collate information. It is considering the argument that sterile barrier systems are part of, or an accessory to, medical devices and should therefore be regulated under the Medical Devices Directive (MDD). Eucomed is looking closely now at existing assessment of sterile barrier systems/materials under the MDD.
You may also be interested in...
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.
Sabinsa provided FDA and FTC with documentation of “an ingredient falsely marketed and sold as vitamin C derived from amla fruit (Emblica officinalis), which two independent labs have confirmed is actually derived from corn, sugarcane or other plants.”
With its US/Mexico Phase III trial delayed due to manufacturing questions, Novavax has aligned its UK study with FDA guidance. It hopes for interim data from that study during Q1 2021.